Hospital payments have dropped $250B

Payments to hospitals have been reduced by more than $250 billion over the last decade, according to a recent study.

The study, which estimates cumulative federal payment reductions to hospitals from 2010 to 2019 beyond those stemming from the Affordable Care Act, was commissioned by the Federation of American Hospitals (FHA) and the American Hospital Association (AHA) and conducted by Dobson DaVanzo & Associates. In total, 12 legislative acts were identified as well as other regulatory actions that reduced payments to hospitals by $252.6 billion over this time period.

A big chunk of those reductions came from sequestration budget cuts in 2011, which were designed to shave $1.2 trillion in federal budget savings over a decade. Expansions of the budget sequestration have also extended hospital payments with cuts to Medicare providers. In total, budget actions have taken $85.8 billion away from hospital in the form of reduced payments.

Other impacts on federal payments to hospitals include:

  • Payment of Medicare bad debt––$5.7B
  • Hospital documentation and coding adjustments––$85.7B
  • Reduction in post-acute care provider payment updates––$7.3B
  • Off-campus provider based hospital outpatient departments––$23.7B
  • Medicare payments for long term care hospitals––$8.1B
  • Clarification of 3-day payment window––$4.2B
  • Hospital transfer policy expanded to hospice––$6.2B
  • Federal Medicaid DSH allotment reductions––$25.9

Find the full report here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.